Novo Nordisk A/S is a pharmaceutical company that specializes in diabetes care medications and devices.

It produces insulin, GLP-1 analogs, obesity drugs, and biopharmaceuticals, as well as insulin pens, needles, and glucose monitoring devices.Digital Innovation Hubs in major health-tech ecosystems worldwide to accelerate digital progress in defeating chronic diseases.

The Hubs will connect with local start-ups and organizations, co-create solutions, and amplify Novo Nordisk's purpose.

The network spans globally, with Hubs already launched in China, UK, Germany, Brazil, and Israel.